Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Physicians | 38 | 2024 | 4591 | 4.420 |
Why?
|
Malpractice | 10 | 2017 | 556 | 2.920 |
Why?
|
Insurance, Liability | 7 | 2017 | 101 | 2.770 |
Why?
|
Wounds, Gunshot | 6 | 2022 | 582 | 2.430 |
Why?
|
Schools, Medical | 8 | 2022 | 879 | 2.280 |
Why?
|
Firearms | 6 | 2023 | 626 | 2.210 |
Why?
|
Personnel Staffing and Scheduling | 8 | 2021 | 495 | 2.200 |
Why?
|
Hospital Mortality | 23 | 2024 | 5293 | 2.110 |
Why?
|
United States | 148 | 2024 | 72340 | 2.090 |
Why?
|
Drug Prescriptions | 12 | 2022 | 1670 | 2.040 |
Why?
|
Medicare | 48 | 2024 | 6770 | 1.940 |
Why?
|
Authorship | 5 | 2023 | 284 | 1.900 |
Why?
|
Physicians, Women | 10 | 2024 | 509 | 1.780 |
Why?
|
Analgesics, Opioid | 16 | 2022 | 3808 | 1.760 |
Why?
|
Health Care Costs | 12 | 2022 | 3242 | 1.760 |
Why?
|
Workload | 8 | 2018 | 844 | 1.600 |
Why?
|
Fraud | 4 | 2021 | 66 | 1.590 |
Why?
|
Quality of Health Care | 13 | 2021 | 4331 | 1.590 |
Why?
|
Income | 10 | 2021 | 1877 | 1.590 |
Why?
|
Family Characteristics | 4 | 2021 | 1004 | 1.560 |
Why?
|
Carbon Monoxide Poisoning | 2 | 2022 | 65 | 1.530 |
Why?
|
Congresses as Topic | 4 | 2018 | 803 | 1.530 |
Why?
|
Hospitalists | 7 | 2024 | 294 | 1.490 |
Why?
|
Medicine | 7 | 2021 | 942 | 1.410 |
Why?
|
Hospitals | 15 | 2023 | 3883 | 1.340 |
Why?
|
Health Personnel | 7 | 2021 | 3335 | 1.290 |
Why?
|
Faculty, Medical | 4 | 2019 | 1204 | 1.260 |
Why?
|
Hospital Costs | 6 | 2017 | 947 | 1.240 |
Why?
|
Drug Utilization | 6 | 2022 | 1188 | 1.180 |
Why?
|
Humans | 233 | 2024 | 761596 | 1.160 |
Why?
|
Fee-for-Service Plans | 11 | 2024 | 700 | 1.140 |
Why?
|
Cultural Diversity | 2 | 2021 | 369 | 1.140 |
Why?
|
Liability, Legal | 4 | 2021 | 210 | 1.130 |
Why?
|
Patient Readmission | 14 | 2024 | 3271 | 1.130 |
Why?
|
Marriage | 2 | 2018 | 351 | 1.040 |
Why?
|
Hospitals, Teaching | 5 | 2018 | 1156 | 1.030 |
Why?
|
Foreign Medical Graduates | 4 | 2021 | 77 | 1.020 |
Why?
|
Physicians, Primary Care | 4 | 2023 | 623 | 1.020 |
Why?
|
Health Services Research | 7 | 2021 | 1812 | 1.010 |
Why?
|
Hospitalization | 17 | 2023 | 10721 | 0.990 |
Why?
|
Sex Distribution | 5 | 2020 | 2280 | 0.970 |
Why?
|
Influenza Vaccines | 2 | 2024 | 768 | 0.950 |
Why?
|
Electric Power Supplies | 2 | 2022 | 96 | 0.940 |
Why?
|
Cost-Benefit Analysis | 16 | 2022 | 5493 | 0.920 |
Why?
|
Social Responsibility | 3 | 2023 | 386 | 0.920 |
Why?
|
Physician's Role | 5 | 2014 | 917 | 0.900 |
Why?
|
Male | 120 | 2024 | 360846 | 0.900 |
Why?
|
Female | 121 | 2024 | 392705 | 0.860 |
Why?
|
Minoxidil | 1 | 2023 | 34 | 0.850 |
Why?
|
Divorce | 2 | 2015 | 75 | 0.850 |
Why?
|
Internship and Residency | 10 | 2019 | 5882 | 0.850 |
Why?
|
Mortality | 4 | 2018 | 2902 | 0.850 |
Why?
|
Emergency Service, Hospital | 15 | 2023 | 7879 | 0.850 |
Why?
|
Biomedical Technology | 3 | 2012 | 211 | 0.830 |
Why?
|
Drug Costs | 4 | 2019 | 1183 | 0.830 |
Why?
|
Students | 4 | 2022 | 1741 | 0.830 |
Why?
|
Censuses | 3 | 2021 | 202 | 0.820 |
Why?
|
Public Policy | 4 | 2022 | 559 | 0.820 |
Why?
|
Opioid-Related Disorders | 4 | 2022 | 2164 | 0.810 |
Why?
|
Leukopenia | 1 | 2023 | 213 | 0.810 |
Why?
|
Football | 2 | 2018 | 503 | 0.800 |
Why?
|
Inpatients | 8 | 2021 | 2548 | 0.780 |
Why?
|
Internal Medicine | 3 | 2017 | 1051 | 0.770 |
Why?
|
Leadership | 4 | 2019 | 1385 | 0.770 |
Why?
|
Sulfhydryl Compounds | 1 | 2023 | 301 | 0.750 |
Why?
|
Sex Factors | 14 | 2024 | 10554 | 0.750 |
Why?
|
Observation | 2 | 2013 | 310 | 0.750 |
Why?
|
Models, Economic | 4 | 2020 | 716 | 0.740 |
Why?
|
Health Expenditures | 10 | 2022 | 2366 | 0.740 |
Why?
|
Influenza, Human | 2 | 2024 | 1521 | 0.730 |
Why?
|
Violence | 3 | 2023 | 937 | 0.730 |
Why?
|
Social Values | 3 | 2020 | 225 | 0.730 |
Why?
|
Politics | 3 | 2022 | 815 | 0.720 |
Why?
|
Delivery of Health Care | 8 | 2021 | 5337 | 0.720 |
Why?
|
Vaccination | 3 | 2024 | 3384 | 0.720 |
Why?
|
Endpoint Determination | 2 | 2013 | 590 | 0.690 |
Why?
|
Heart Arrest | 5 | 2017 | 1514 | 0.680 |
Why?
|
Pneumonia, Bacterial | 2 | 2013 | 317 | 0.680 |
Why?
|
Quality Assurance, Health Care | 4 | 2019 | 2169 | 0.680 |
Why?
|
Methyltransferases | 1 | 2023 | 377 | 0.680 |
Why?
|
Reimbursement, Incentive | 3 | 2017 | 543 | 0.680 |
Why?
|
Cardiology | 4 | 2017 | 1656 | 0.680 |
Why?
|
Health Occupations | 1 | 2021 | 222 | 0.670 |
Why?
|
Health Policy | 6 | 2021 | 2684 | 0.670 |
Why?
|
Purines | 1 | 2023 | 607 | 0.660 |
Why?
|
Retrospective Studies | 44 | 2024 | 80647 | 0.660 |
Why?
|
Medicare Part D | 3 | 2017 | 355 | 0.660 |
Why?
|
Group Practice | 1 | 2020 | 151 | 0.660 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1032 | 0.650 |
Why?
|
Epidemics | 2 | 2022 | 512 | 0.650 |
Why?
|
Foreign Professional Personnel | 1 | 2018 | 9 | 0.650 |
Why?
|
Weather | 1 | 2020 | 231 | 0.650 |
Why?
|
Aged | 73 | 2024 | 169310 | 0.650 |
Why?
|
Golf | 1 | 2018 | 16 | 0.650 |
Why?
|
Mass Casualty Incidents | 1 | 2021 | 179 | 0.640 |
Why?
|
Technology Assessment, Biomedical | 3 | 2022 | 307 | 0.640 |
Why?
|
Cross-Sectional Studies | 24 | 2024 | 26129 | 0.630 |
Why?
|
Nurse Anesthetists | 1 | 2018 | 24 | 0.630 |
Why?
|
Alopecia | 1 | 2023 | 412 | 0.630 |
Why?
|
Peer Review, Research | 1 | 2022 | 340 | 0.620 |
Why?
|
Professional Misconduct | 1 | 2018 | 73 | 0.610 |
Why?
|
Gynecology | 1 | 2024 | 526 | 0.610 |
Why?
|
Compensation and Redress | 2 | 2017 | 66 | 0.600 |
Why?
|
Inappropriate Prescribing | 5 | 2022 | 211 | 0.600 |
Why?
|
Employment | 1 | 2024 | 1118 | 0.590 |
Why?
|
Rain | 1 | 2017 | 60 | 0.590 |
Why?
|
Proton Pump Inhibitors | 2 | 2013 | 532 | 0.590 |
Why?
|
Contract Services | 1 | 2017 | 89 | 0.590 |
Why?
|
Hypolipidemic Agents | 3 | 2021 | 609 | 0.590 |
Why?
|
Long-Term Care | 1 | 2022 | 633 | 0.580 |
Why?
|
Publications | 2 | 2021 | 194 | 0.580 |
Why?
|
Staff Development | 1 | 2019 | 228 | 0.580 |
Why?
|
Prescription Fees | 2 | 2016 | 153 | 0.570 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 3204 | 0.570 |
Why?
|
Child Care | 1 | 2018 | 124 | 0.570 |
Why?
|
Tissue and Organ Procurement | 2 | 2023 | 962 | 0.550 |
Why?
|
Biopharmaceutics | 1 | 2016 | 23 | 0.550 |
Why?
|
Women, Working | 1 | 2017 | 86 | 0.550 |
Why?
|
Sexually Transmitted Diseases | 2 | 2015 | 662 | 0.550 |
Why?
|
Policy Making | 2 | 2017 | 542 | 0.550 |
Why?
|
Telemedicine | 4 | 2022 | 3052 | 0.550 |
Why?
|
Salaries and Fringe Benefits | 2 | 2016 | 257 | 0.550 |
Why?
|
Causality | 2 | 2013 | 1242 | 0.540 |
Why?
|
Transplants | 1 | 2019 | 206 | 0.540 |
Why?
|
Patient Discharge | 5 | 2022 | 3443 | 0.540 |
Why?
|
Advance Care Planning | 2 | 2024 | 699 | 0.530 |
Why?
|
Cardiology Service, Hospital | 1 | 2018 | 239 | 0.520 |
Why?
|
Insurance Claim Review | 6 | 2021 | 741 | 0.520 |
Why?
|
Transportation of Patients | 1 | 2017 | 174 | 0.520 |
Why?
|
Disasters | 1 | 2022 | 519 | 0.520 |
Why?
|
Bibliometrics | 3 | 2021 | 352 | 0.520 |
Why?
|
Conflict of Interest | 1 | 2021 | 554 | 0.520 |
Why?
|
Specialization | 5 | 2021 | 778 | 0.510 |
Why?
|
Chlorofluorocarbons | 1 | 2015 | 12 | 0.510 |
Why?
|
Middle Aged | 53 | 2024 | 220921 | 0.510 |
Why?
|
Aging, Premature | 1 | 2015 | 44 | 0.510 |
Why?
|
Famous Persons | 1 | 2016 | 109 | 0.510 |
Why?
|
Schools | 1 | 2024 | 1489 | 0.500 |
Why?
|
Preventive Health Services | 1 | 2020 | 567 | 0.500 |
Why?
|
Aged, 80 and over | 34 | 2024 | 58984 | 0.500 |
Why?
|
Adult | 46 | 2024 | 221210 | 0.490 |
Why?
|
Prescription Drugs | 3 | 2015 | 631 | 0.490 |
Why?
|
Publishing | 2 | 2019 | 833 | 0.490 |
Why?
|
Government | 1 | 2015 | 161 | 0.480 |
Why?
|
Health Plan Implementation | 2 | 2021 | 337 | 0.470 |
Why?
|
Emigration and Immigration | 1 | 2017 | 397 | 0.470 |
Why?
|
Nebulizers and Vaporizers | 1 | 2015 | 139 | 0.470 |
Why?
|
Automobile Driving | 1 | 2019 | 441 | 0.470 |
Why?
|
Accident Prevention | 1 | 2014 | 76 | 0.470 |
Why?
|
Career Choice | 1 | 2020 | 756 | 0.460 |
Why?
|
Albuterol | 1 | 2015 | 213 | 0.460 |
Why?
|
Age Factors | 10 | 2024 | 18399 | 0.460 |
Why?
|
Terminal Care | 3 | 2024 | 1761 | 0.450 |
Why?
|
Wounds and Injuries | 3 | 2024 | 2492 | 0.450 |
Why?
|
Postoperative Complications | 6 | 2022 | 15633 | 0.450 |
Why?
|
Accreditation | 1 | 2017 | 473 | 0.450 |
Why?
|
Cost of Illness | 3 | 2020 | 1937 | 0.450 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2016 | 629 | 0.450 |
Why?
|
Back Pain | 1 | 2017 | 545 | 0.450 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1063 | 0.440 |
Why?
|
Arthralgia | 1 | 2017 | 461 | 0.440 |
Why?
|
Myocardial Infarction | 7 | 2020 | 11461 | 0.440 |
Why?
|
Quality Improvement | 2 | 2021 | 3802 | 0.440 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3708 | 0.430 |
Why?
|
Internet | 3 | 2024 | 3093 | 0.430 |
Why?
|
Cross Infection | 2 | 2013 | 1422 | 0.430 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 166 | 0.430 |
Why?
|
Career Mobility | 1 | 2015 | 259 | 0.430 |
Why?
|
Reimbursement Mechanisms | 2 | 2019 | 667 | 0.430 |
Why?
|
Cost Sharing | 2 | 2016 | 409 | 0.420 |
Why?
|
Life Expectancy | 3 | 2018 | 1243 | 0.420 |
Why?
|
Drug Approval | 3 | 2019 | 814 | 0.420 |
Why?
|
Tachycardia | 1 | 2015 | 600 | 0.420 |
Why?
|
Professional Role | 1 | 2015 | 314 | 0.420 |
Why?
|
Periodicals as Topic | 4 | 2021 | 1463 | 0.410 |
Why?
|
Organ Transplantation | 1 | 2023 | 1157 | 0.410 |
Why?
|
Health Care Reform | 3 | 2014 | 1247 | 0.410 |
Why?
|
Epidemiologic Research Design | 1 | 2016 | 368 | 0.410 |
Why?
|
Insurance, Health | 7 | 2022 | 2499 | 0.410 |
Why?
|
Regression Analysis | 4 | 2021 | 6345 | 0.410 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1285 | 0.410 |
Why?
|
Seasons | 2 | 2020 | 1520 | 0.400 |
Why?
|
Quality-Adjusted Life Years | 6 | 2022 | 1722 | 0.400 |
Why?
|
Running | 1 | 2017 | 488 | 0.400 |
Why?
|
Drug Industry | 3 | 2017 | 788 | 0.400 |
Why?
|
Guideline Adherence | 5 | 2021 | 2220 | 0.400 |
Why?
|
Advanced Cardiac Life Support | 4 | 2016 | 78 | 0.400 |
Why?
|
Pandemics | 8 | 2024 | 8656 | 0.400 |
Why?
|
Heart Diseases | 2 | 2015 | 2781 | 0.400 |
Why?
|
Safety | 2 | 2014 | 1149 | 0.390 |
Why?
|
End Stage Liver Disease | 1 | 2016 | 352 | 0.390 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 512 | 0.390 |
Why?
|
Search Engine | 1 | 2013 | 143 | 0.380 |
Why?
|
Coronary Artery Bypass | 2 | 2020 | 2188 | 0.380 |
Why?
|
School Admission Criteria | 1 | 2012 | 107 | 0.380 |
Why?
|
Emergency Medical Services | 4 | 2017 | 1923 | 0.380 |
Why?
|
Negotiating | 1 | 2013 | 150 | 0.380 |
Why?
|
Florida | 3 | 2019 | 431 | 0.380 |
Why?
|
Education, Medical | 2 | 2013 | 1725 | 0.370 |
Why?
|
Hyperlipidemias | 1 | 2016 | 771 | 0.370 |
Why?
|
Psychology, Industrial | 1 | 2010 | 7 | 0.370 |
Why?
|
Mothers | 1 | 2021 | 2198 | 0.370 |
Why?
|
Students, Medical | 2 | 2022 | 1936 | 0.370 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 2001 | 0.360 |
Why?
|
Chronic Disease | 4 | 2022 | 9319 | 0.360 |
Why?
|
Homicide | 1 | 2013 | 294 | 0.360 |
Why?
|
Economics, Hospital | 1 | 2013 | 210 | 0.360 |
Why?
|
Population Surveillance | 1 | 2021 | 2598 | 0.360 |
Why?
|
Models, Econometric | 3 | 2020 | 216 | 0.360 |
Why?
|
Pain | 2 | 2016 | 5073 | 0.360 |
Why?
|
Drug Discovery | 1 | 2018 | 1051 | 0.350 |
Why?
|
Law Enforcement | 1 | 2011 | 112 | 0.350 |
Why?
|
Clinical Competence | 4 | 2021 | 4793 | 0.350 |
Why?
|
Asthma | 3 | 2020 | 6234 | 0.350 |
Why?
|
Pregnancy, Multiple | 1 | 2011 | 215 | 0.350 |
Why?
|
Diffusion of Innovation | 4 | 2021 | 728 | 0.350 |
Why?
|
Minority Groups | 3 | 2022 | 1203 | 0.340 |
Why?
|
Time Factors | 13 | 2024 | 39969 | 0.340 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1613 | 0.340 |
Why?
|
Socioeconomic Factors | 5 | 2016 | 7828 | 0.330 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3358 | 0.330 |
Why?
|
Twins | 1 | 2011 | 339 | 0.330 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2020 | 0.330 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 214 | 0.330 |
Why?
|
Length of Stay | 4 | 2017 | 6426 | 0.330 |
Why?
|
Patient Transfer | 1 | 2016 | 794 | 0.320 |
Why?
|
Diagnostic Errors | 2 | 2017 | 1265 | 0.320 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7406 | 0.320 |
Why?
|
Registries | 4 | 2023 | 8225 | 0.320 |
Why?
|
Odds Ratio | 7 | 2024 | 9647 | 0.320 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 13642 | 0.310 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 496 | 0.310 |
Why?
|
Ambulances | 2 | 2021 | 91 | 0.310 |
Why?
|
Personnel Turnover | 2 | 2021 | 88 | 0.310 |
Why?
|
Mastectomy | 1 | 2016 | 1822 | 0.310 |
Why?
|
Anesthesiology | 1 | 2018 | 1120 | 0.310 |
Why?
|
Age Distribution | 4 | 2019 | 2879 | 0.300 |
Why?
|
Substance-Related Disorders | 3 | 2022 | 4420 | 0.300 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2422 | 0.300 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12059 | 0.300 |
Why?
|
Neoplasms | 8 | 2023 | 22173 | 0.300 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1336 | 0.300 |
Why?
|
Pharmaceutical Services | 1 | 2009 | 141 | 0.300 |
Why?
|
Antidepressive Agents | 1 | 2020 | 2897 | 0.290 |
Why?
|
Pre-Eclampsia | 1 | 2017 | 1231 | 0.290 |
Why?
|
Emergency Medicine | 1 | 2017 | 1198 | 0.290 |
Why?
|
Medical Errors | 1 | 2016 | 1263 | 0.290 |
Why?
|
Anesthesia | 1 | 2018 | 1595 | 0.290 |
Why?
|
Hypothermia, Induced | 1 | 2012 | 753 | 0.280 |
Why?
|
Databases, Factual | 8 | 2020 | 7968 | 0.280 |
Why?
|
Comparative Effectiveness Research | 4 | 2014 | 709 | 0.280 |
Why?
|
Electrocardiography | 1 | 2020 | 6377 | 0.280 |
Why?
|
Incidence | 9 | 2021 | 21355 | 0.280 |
Why?
|
Erectile Dysfunction | 1 | 2010 | 444 | 0.270 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2382 | 0.270 |
Why?
|
Models, Statistical | 4 | 2016 | 5079 | 0.270 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1175 | 0.270 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3201 | 0.270 |
Why?
|
Self Report | 2 | 2015 | 3725 | 0.270 |
Why?
|
Ownership | 2 | 2021 | 339 | 0.260 |
Why?
|
Biomedical Research | 4 | 2018 | 3429 | 0.260 |
Why?
|
Suicide | 2 | 2014 | 1602 | 0.260 |
Why?
|
Vasodilator Agents | 1 | 2010 | 973 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2021 | 3246 | 0.260 |
Why?
|
Child | 14 | 2024 | 80158 | 0.260 |
Why?
|
Atrial Fibrillation | 3 | 2021 | 5127 | 0.260 |
Why?
|
Research Design | 3 | 2018 | 6180 | 0.250 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6815 | 0.250 |
Why?
|
Mammography | 1 | 2016 | 2430 | 0.240 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2190 | 0.240 |
Why?
|
Blood Glucose | 1 | 2019 | 6391 | 0.240 |
Why?
|
Surgical Procedures, Operative | 3 | 2021 | 1924 | 0.240 |
Why?
|
Homosexuality, Male | 1 | 2013 | 1334 | 0.240 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11742 | 0.240 |
Why?
|
Life Support Care | 2 | 2016 | 226 | 0.230 |
Why?
|
Sulfonylurea Compounds | 2 | 2016 | 219 | 0.230 |
Why?
|
Liver Transplantation | 1 | 2016 | 2330 | 0.230 |
Why?
|
Logistic Models | 5 | 2017 | 13255 | 0.230 |
Why?
|
Health Behavior | 1 | 2015 | 2644 | 0.220 |
Why?
|
Osteopathic Physicians | 1 | 2023 | 1 | 0.220 |
Why?
|
Life Style | 1 | 2015 | 3917 | 0.220 |
Why?
|
Respiratory Tract Infections | 2 | 2021 | 1010 | 0.220 |
Why?
|
Genetic Testing | 1 | 2016 | 3537 | 0.220 |
Why?
|
Efficiency, Organizational | 1 | 2008 | 695 | 0.220 |
Why?
|
Young Adult | 9 | 2023 | 59260 | 0.220 |
Why?
|
Cohort Studies | 8 | 2024 | 41495 | 0.210 |
Why?
|
Information Seeking Behavior | 1 | 2024 | 116 | 0.210 |
Why?
|
Motorcycles | 1 | 2023 | 42 | 0.210 |
Why?
|
Pyrophosphatases | 1 | 2023 | 142 | 0.200 |
Why?
|
United States Food and Drug Administration | 5 | 2023 | 1664 | 0.200 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1403 | 0.200 |
Why?
|
Inosine | 1 | 2023 | 130 | 0.200 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4762 | 0.200 |
Why?
|
Ivermectin | 1 | 2022 | 46 | 0.200 |
Why?
|
Commerce | 1 | 2007 | 607 | 0.190 |
Why?
|
Epoetin Alfa | 1 | 2021 | 78 | 0.190 |
Why?
|
Educational Status | 3 | 2017 | 2522 | 0.190 |
Why?
|
Communication | 2 | 2012 | 3875 | 0.190 |
Why?
|
Evidence-Based Medicine | 4 | 2020 | 3688 | 0.190 |
Why?
|
Emergency Treatment | 2 | 2015 | 496 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 15502 | 0.190 |
Why?
|
Fibric Acids | 1 | 2021 | 27 | 0.190 |
Why?
|
Public Sector | 2 | 2016 | 267 | 0.180 |
Why?
|
Demography | 2 | 2016 | 1648 | 0.180 |
Why?
|
Holidays | 1 | 2020 | 40 | 0.180 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2015 | 339 | 0.180 |
Why?
|
Ambulatory Care | 2 | 2022 | 2775 | 0.180 |
Why?
|
Treatment Outcome | 12 | 2021 | 64685 | 0.180 |
Why?
|
Survival Analysis | 6 | 2021 | 10090 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 4016 | 0.180 |
Why?
|
Marketing | 1 | 2022 | 220 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 12149 | 0.170 |
Why?
|
Health Services Misuse | 2 | 2019 | 244 | 0.170 |
Why?
|
Parturition | 1 | 2024 | 448 | 0.170 |
Why?
|
Amiodarone | 1 | 2021 | 217 | 0.170 |
Why?
|
Prevalence | 5 | 2016 | 15733 | 0.170 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12463 | 0.170 |
Why?
|
Fluoroquinolones | 1 | 2021 | 307 | 0.170 |
Why?
|
Pediatrics | 2 | 2017 | 3589 | 0.160 |
Why?
|
Risk | 4 | 2017 | 9610 | 0.160 |
Why?
|
Electronic Health Records | 1 | 2016 | 4811 | 0.160 |
Why?
|
Cost Control | 2 | 2014 | 628 | 0.160 |
Why?
|
Personnel Management | 1 | 2018 | 52 | 0.160 |
Why?
|
History, 20th Century | 2 | 2018 | 2767 | 0.160 |
Why?
|
Policy | 1 | 2022 | 509 | 0.160 |
Why?
|
Hypoglycemia | 2 | 2016 | 883 | 0.160 |
Why?
|
Nutrition Surveys | 2 | 2016 | 1733 | 0.160 |
Why?
|
Adolescent | 11 | 2022 | 88326 | 0.160 |
Why?
|
Prognosis | 2 | 2016 | 29629 | 0.150 |
Why?
|
HIV Infections | 3 | 2015 | 17354 | 0.150 |
Why?
|
Sleep Medicine Specialty | 1 | 2018 | 71 | 0.150 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 426 | 0.150 |
Why?
|
Biological Science Disciplines | 1 | 2018 | 57 | 0.150 |
Why?
|
Fetal Distress | 1 | 2017 | 39 | 0.150 |
Why?
|
Sweden | 1 | 2020 | 1379 | 0.150 |
Why?
|
Warfarin | 2 | 2016 | 1483 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2021 | 385 | 0.140 |
Why?
|
Health Status | 1 | 2010 | 4077 | 0.140 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2017 | 92 | 0.140 |
Why?
|
Oxycodone | 1 | 2018 | 139 | 0.140 |
Why?
|
Organizations | 1 | 2018 | 171 | 0.140 |
Why?
|
Administration, Oral | 2 | 2023 | 4021 | 0.140 |
Why?
|
Hypogonadism | 1 | 2023 | 798 | 0.140 |
Why?
|
Cause of Death | 2 | 2018 | 3683 | 0.140 |
Why?
|
Hospitals, University | 1 | 2018 | 564 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2018 | 10212 | 0.140 |
Why?
|
Markov Chains | 2 | 2020 | 966 | 0.140 |
Why?
|
Pulmonary Medicine | 1 | 2018 | 221 | 0.130 |
Why?
|
Insurance Coverage | 3 | 2017 | 1940 | 0.130 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.130 |
Why?
|
Hospitals, Community | 1 | 2018 | 365 | 0.130 |
Why?
|
Organizational Culture | 2 | 2018 | 509 | 0.130 |
Why?
|
Leukomalacia, Periventricular | 1 | 2017 | 184 | 0.130 |
Why?
|
Rural Population | 2 | 2017 | 2287 | 0.130 |
Why?
|
Medicare Part B | 1 | 2017 | 117 | 0.130 |
Why?
|
Glipizide | 1 | 2015 | 48 | 0.130 |
Why?
|
Medical Oncology | 2 | 2023 | 2321 | 0.130 |
Why?
|
Hospitals, Proprietary | 1 | 2015 | 39 | 0.130 |
Why?
|
Medicaid | 4 | 2020 | 2818 | 0.130 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 3085 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2017 | 233 | 0.130 |
Why?
|
Patients | 1 | 2022 | 907 | 0.120 |
Why?
|
California | 3 | 2018 | 1430 | 0.120 |
Why?
|
Workplace | 2 | 2012 | 863 | 0.120 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5440 | 0.120 |
Why?
|
Child, Preschool | 5 | 2024 | 42232 | 0.120 |
Why?
|
Nurses | 1 | 2024 | 2478 | 0.120 |
Why?
|
Pain, Postoperative | 2 | 2022 | 1740 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 13367 | 0.120 |
Why?
|
Licensure | 2 | 2022 | 128 | 0.120 |
Why?
|
Mandatory Programs | 1 | 2015 | 86 | 0.120 |
Why?
|
Air Pollution, Indoor | 1 | 2022 | 901 | 0.120 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2022 | 1393 | 0.110 |
Why?
|
Waiting Lists | 1 | 2019 | 765 | 0.110 |
Why?
|
Physical Examination | 1 | 2020 | 1255 | 0.110 |
Why?
|
Pregnancy | 4 | 2024 | 29890 | 0.110 |
Why?
|
Herpes Genitalis | 1 | 2015 | 150 | 0.110 |
Why?
|
Universities | 1 | 2019 | 993 | 0.110 |
Why?
|
Drug and Narcotic Control | 1 | 2015 | 144 | 0.110 |
Why?
|
Outpatients | 2 | 2021 | 1597 | 0.110 |
Why?
|
Postpartum Hemorrhage | 1 | 2017 | 272 | 0.110 |
Why?
|
Genes, BRCA2 | 1 | 2016 | 601 | 0.110 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2017 | 326 | 0.110 |
Why?
|
Benzodiazepines | 1 | 2019 | 1132 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.110 |
Why?
|
Exercise | 1 | 2010 | 5890 | 0.110 |
Why?
|
Unsafe Sex | 1 | 2015 | 238 | 0.110 |
Why?
|
Tissue Donors | 1 | 2023 | 2332 | 0.110 |
Why?
|
Physician Impairment | 1 | 2013 | 72 | 0.110 |
Why?
|
Legislation as Topic | 1 | 2013 | 77 | 0.100 |
Why?
|
Genes, BRCA1 | 1 | 2016 | 764 | 0.100 |
Why?
|
Risk Management | 1 | 2016 | 558 | 0.100 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21019 | 0.100 |
Why?
|
Syphilis | 1 | 2015 | 243 | 0.100 |
Why?
|
Testosterone | 1 | 2023 | 2472 | 0.100 |
Why?
|
State Medicine | 1 | 2014 | 216 | 0.100 |
Why?
|
Administration, Inhalation | 1 | 2015 | 1157 | 0.100 |
Why?
|
Hypoxia, Brain | 1 | 2012 | 138 | 0.100 |
Why?
|
Physicians' Offices | 2 | 2022 | 60 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1509 | 0.100 |
Why?
|
Cost Savings | 1 | 2017 | 913 | 0.100 |
Why?
|
Urinary Tract Infections | 2 | 2021 | 802 | 0.100 |
Why?
|
Sick Leave | 1 | 2012 | 105 | 0.100 |
Why?
|
Critical Care | 3 | 2020 | 2697 | 0.100 |
Why?
|
Chlamydia Infections | 1 | 2015 | 365 | 0.100 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 1668 | 0.100 |
Why?
|
Risk Assessment | 4 | 2021 | 23996 | 0.090 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1400 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 823 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.090 |
Why?
|
Gonorrhea | 1 | 2015 | 346 | 0.090 |
Why?
|
Attitude of Health Personnel | 2 | 2018 | 3889 | 0.090 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1081 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1258 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1553 | 0.090 |
Why?
|
Risk Adjustment | 1 | 2014 | 600 | 0.090 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2014 | 857 | 0.090 |
Why?
|
Anticoagulants | 2 | 2016 | 4812 | 0.090 |
Why?
|
Professional Competence | 1 | 2013 | 431 | 0.090 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2011 | 166 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2017 | 558 | 0.090 |
Why?
|
Financing, Government | 1 | 2014 | 472 | 0.090 |
Why?
|
Europe | 2 | 2015 | 3420 | 0.080 |
Why?
|
Emergencies | 1 | 2016 | 1217 | 0.080 |
Why?
|
Nephrectomy | 1 | 2015 | 937 | 0.080 |
Why?
|
Health Priorities | 1 | 2012 | 374 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 966 | 0.080 |
Why?
|
Sample Size | 1 | 2013 | 841 | 0.080 |
Why?
|
Burnout, Professional | 1 | 2018 | 704 | 0.080 |
Why?
|
Patient Admission | 1 | 2017 | 1367 | 0.080 |
Why?
|
Adenoma | 1 | 2020 | 2163 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1182 | 0.080 |
Why?
|
Work Schedule Tolerance | 1 | 2013 | 551 | 0.080 |
Why?
|
Economics | 1 | 2010 | 141 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2017 | 1188 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1567 | 0.080 |
Why?
|
Prescriptions | 2 | 2022 | 386 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2015 | 809 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2013 | 2927 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2016 | 2426 | 0.080 |
Why?
|
Family Relations | 1 | 2011 | 317 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2689 | 0.080 |
Why?
|
Risk Factors | 7 | 2021 | 74213 | 0.080 |
Why?
|
Marital Status | 1 | 2010 | 426 | 0.080 |
Why?
|
Community-Acquired Infections | 1 | 2012 | 469 | 0.080 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2013 | 452 | 0.080 |
Why?
|
Gestational Age | 1 | 2017 | 3577 | 0.080 |
Why?
|
Consensus | 1 | 2018 | 3124 | 0.080 |
Why?
|
Mental Disorders | 2 | 2018 | 6845 | 0.070 |
Why?
|
Fees and Charges | 2 | 2021 | 192 | 0.070 |
Why?
|
Comorbidity | 2 | 2012 | 10508 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2242 | 0.070 |
Why?
|
Psychiatry | 1 | 2019 | 1693 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1469 | 0.070 |
Why?
|
Primary Health Care | 2 | 2021 | 4687 | 0.070 |
Why?
|
Anti-Asthmatic Agents | 1 | 2012 | 574 | 0.070 |
Why?
|
Heart Failure | 4 | 2022 | 11671 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2176 | 0.070 |
Why?
|
Cesarean Section | 1 | 2015 | 1398 | 0.070 |
Why?
|
Specialties, Surgical | 1 | 2011 | 389 | 0.070 |
Why?
|
Investments | 1 | 2008 | 147 | 0.070 |
Why?
|
General Surgery | 1 | 2018 | 1692 | 0.070 |
Why?
|
Counseling | 1 | 2014 | 1547 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1297 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2021 | 774 | 0.070 |
Why?
|
Health Care Sector | 1 | 2008 | 195 | 0.070 |
Why?
|
Fatigue | 1 | 2013 | 1552 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1386 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2691 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3551 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1998 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2656 | 0.060 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.060 |
Why?
|
Heart | 1 | 2019 | 4404 | 0.060 |
Why?
|
Chest Pain | 1 | 2012 | 1091 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2014 | 1177 | 0.060 |
Why?
|
Developed Countries | 1 | 2008 | 449 | 0.060 |
Why?
|
Pneumonia | 2 | 2014 | 2143 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2012 | 2696 | 0.060 |
Why?
|
Disease Transmission, Infectious | 1 | 2010 | 560 | 0.060 |
Why?
|
Data Collection | 2 | 2012 | 3322 | 0.060 |
Why?
|
Osteoarthritis | 1 | 2012 | 1063 | 0.060 |
Why?
|
Private Sector | 1 | 2007 | 398 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2957 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2017 | 26202 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4195 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2017 | 3744 | 0.050 |
Why?
|
Kidney | 1 | 2019 | 7048 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14608 | 0.050 |
Why?
|
Sepsis | 1 | 2017 | 2585 | 0.050 |
Why?
|
Liver | 1 | 2019 | 7528 | 0.050 |
Why?
|
Military Personnel | 1 | 2012 | 1246 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8002 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5872 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9053 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3415 | 0.050 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2021 | 36 | 0.050 |
Why?
|
Radiology | 1 | 2015 | 2113 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2521 | 0.050 |
Why?
|
Defensive Medicine | 1 | 2021 | 47 | 0.050 |
Why?
|
Off-Label Use | 1 | 2023 | 185 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2013 | 2373 | 0.050 |
Why?
|
Bronchitis | 1 | 2021 | 196 | 0.050 |
Why?
|
Program Evaluation | 1 | 2009 | 2495 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14665 | 0.050 |
Why?
|
Tuberculosis, Spinal | 1 | 2000 | 16 | 0.050 |
Why?
|
Lung | 1 | 2019 | 10002 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39106 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10766 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6938 | 0.040 |
Why?
|
Fenofibrate | 1 | 2020 | 87 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9177 | 0.040 |
Why?
|
Patient Preference | 2 | 2020 | 927 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12723 | 0.040 |
Why?
|
Stroke | 4 | 2015 | 9758 | 0.040 |
Why?
|
Drug Labeling | 1 | 2021 | 248 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22176 | 0.040 |
Why?
|
Occult Blood | 1 | 2020 | 198 | 0.040 |
Why?
|
Research | 1 | 2007 | 1982 | 0.040 |
Why?
|
Hematinics | 1 | 2021 | 282 | 0.040 |
Why?
|
Financing, Personal | 2 | 2012 | 309 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4251 | 0.040 |
Why?
|
Morphine | 1 | 2022 | 657 | 0.040 |
Why?
|
Symporters | 1 | 2001 | 363 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2001 | 406 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20100 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3575 | 0.040 |
Why?
|
Motivation | 1 | 2007 | 2006 | 0.040 |
Why?
|
Office Visits | 1 | 2021 | 595 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 914 | 0.030 |
Why?
|
Schizophrenia | 2 | 2013 | 6937 | 0.030 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2009 | 348 | 0.030 |
Why?
|
General Practice | 1 | 2017 | 97 | 0.030 |
Why?
|
Glyburide | 1 | 2016 | 116 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1814 | 0.030 |
Why?
|
Surgery Department, Hospital | 1 | 2017 | 176 | 0.030 |
Why?
|
Medicare Part C | 1 | 2021 | 334 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3206 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 415 | 0.030 |
Why?
|
Hospital Records | 1 | 2015 | 93 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2001 | 1035 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36193 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17904 | 0.030 |
Why?
|
Craniotomy | 1 | 2019 | 741 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 982 | 0.030 |
Why?
|
Asia | 1 | 2015 | 619 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7391 | 0.030 |
Why?
|
Hip Fractures | 2 | 2013 | 988 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2017 | 376 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2015 | 348 | 0.030 |
Why?
|
Time | 1 | 2015 | 546 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2330 | 0.030 |
Why?
|
Mitral Valve | 1 | 2021 | 1465 | 0.030 |
Why?
|
Employee Performance Appraisal | 1 | 2013 | 86 | 0.030 |
Why?
|
Family | 1 | 2023 | 3195 | 0.030 |
Why?
|
Sinusitis | 1 | 2021 | 991 | 0.030 |
Why?
|
Hospitals, General | 1 | 2016 | 798 | 0.030 |
Why?
|
Colonoscopy | 1 | 2020 | 1394 | 0.020 |
Why?
|
North America | 1 | 2015 | 1276 | 0.020 |
Why?
|
Drug Interactions | 1 | 2016 | 1416 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2015 | 916 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1001 | 0.020 |
Why?
|
Health Facility Size | 1 | 2011 | 61 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7237 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6312 | 0.020 |
Why?
|
Gastroenterology | 1 | 2017 | 577 | 0.020 |
Why?
|
Military Medicine | 1 | 2012 | 184 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2639 | 0.020 |
Why?
|
Value of Life | 1 | 2010 | 98 | 0.020 |
Why?
|
SEER Program | 1 | 2015 | 1450 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2690 | 0.020 |
Why?
|
Patient Care Management | 1 | 2013 | 302 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3563 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4061 | 0.020 |
Why?
|
Antipsychotic Agents | 2 | 2013 | 3067 | 0.020 |
Why?
|
Palliative Care | 1 | 2024 | 3598 | 0.020 |
Why?
|
Government Programs | 1 | 2011 | 279 | 0.020 |
Why?
|
Escherichia coli | 1 | 2001 | 4217 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1413 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4853 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1913 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1230 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1615 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.020 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2007 | 321 | 0.020 |
Why?
|
Lactones | 1 | 2007 | 317 | 0.010 |
Why?
|
Sulfones | 1 | 2007 | 448 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3251 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8833 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2011 | 1116 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3462 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3250 | 0.010 |
Why?
|
Patient Participation | 1 | 2011 | 1445 | 0.010 |
Why?
|
Forecasting | 1 | 2011 | 2928 | 0.010 |
Why?
|
Melibiose | 1 | 2001 | 3 | 0.010 |
Why?
|
Galactosides | 1 | 2001 | 54 | 0.010 |
Why?
|
Cations | 1 | 2001 | 238 | 0.010 |
Why?
|
Paraplegia | 1 | 2000 | 161 | 0.010 |
Why?
|
Quadriplegia | 1 | 2000 | 226 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2001 | 1229 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1693 | 0.010 |
Why?
|
Biological Transport | 1 | 2001 | 2091 | 0.010 |
Why?
|
Mass Screening | 1 | 2010 | 5429 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6374 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54423 | 0.010 |
Why?
|
Models, Molecular | 1 | 2001 | 5439 | 0.010 |
Why?
|
Mutation | 1 | 2001 | 30053 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 36426 | 0.000 |
Why?
|